Introduction: This COVID 19 pandemic has altered the routine practices and the acute management of PAH patients. Patients with pre-existing PAH are very sensitive to the changes in their cardiopulmonary status. Objective: To study a case of early pulmonary hypertension in COVID 19. Case Report: A 45-year-old male presented with complaints of breathlessness at rest for 15 days which was gradually progressive. PCR was done and tested positive. The patient was treated for the same with negative PCR repeated report after 14 days and then again patient presented with the above complaints after 14 days of discharge. COVID-19 infection poses a bizarre threat to the vulnerable population with PAH. The inpatient needs have been increased during the pandemic. Observations: PAH patients had great difficulty in surviving the interventions which pose a significant cost during a pandemic that is stretching the health care system. So far, we have not seen many PAH patients with COVID-19 infections, and most of them have had favorable outcomes. This reflects the ability of these patients to isolate and quarantine themselves properly. Also, we are approaching having a successful treatment option or a vaccination for COVID-19 shortly. Conclusion: In the current report, PH was associated with clinical, imaging and laboratory findings of more severe post-COVID-19 and with no morbid outcomes. A final decision is yet to be made. We believe it is important to screen for COVID-19 infection in all patients.